Avella Specialty Pharmacy was a prominent national provider of specialty medications and tailored clinical programs for patients with complex, chronic, or rare diseases such as Hepatitis C, HIV, oncology, and autoimmune disorders. Known for its high-touch patient care model, clinical expertise, and innovative technology solutions, Avella focused on improving medication adherence and patient outcomes. The company grew significantly throughout its operations, eventually being acquired by OptumRx, a part of UnitedHealth Group, in early 2018. This acquisition aimed to enhance Optum's specialty pharmacy capabilities and expand patient access to specialized care.
Served as the primary corporate office, overseeing national operations, strategic planning, clinical program development, financial management, and administrative functions for Avella Specialty Pharmacy prior to its acquisition.
The Scottsdale headquarters was situated in a modern office building within a recognized business district, providing professional workspace. Specific unique architectural highlights were not widely publicized; the focus was on functional and efficient operations.
Prior to its acquisition, Avella's HQ work culture likely emphasized collaboration, patient-centricity, and clinical excellence, reflecting its mission in specialty pharmacy. Employees were part of a rapidly growing company in a dynamic healthcare sector, requiring adaptability and a strong focus on compliance and quality care.
This headquarters was the nerve center for Avella's nationwide operations and strategic initiatives during its period of significant growth and establishment as a leading independent specialty pharmacy.
Prior to its acquisition by Optum, Avella Specialty Pharmacy operated primarily within the United States. It established a national footprint through a combination of mail-order dispensing capabilities, physical pharmacy locations in various states, and comprehensive patient support programs. This allowed Avella to serve patients requiring specialty medications for complex and chronic conditions across the country, regardless of their geographic location.
4800 N Scottsdale Rd, Suite 4500
Scottsdale
AZ
USA
Address: 2441 W Peoria Ave, Phoenix, AZ 85029
Acted as a primary dispensing and patient care facility, particularly for patients in the Southwest, and supported national mail-order fulfillment.
Address: 915 Taylor Station Road, Suite G, Gahanna, OH 43230
Provided localized access to specialty medications, clinical support, and services for patients located in Ohio and the broader Midwest region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Avella Specialty Pharmacy' leadership includes:
Avella Specialty Pharmacy has been backed by several prominent investors over the years, including:
The most significant executive changes for Avella Specialty Pharmacy occurred around its acquisition by Optum in early 2018. Such acquisitions typically lead to leadership transitions as the acquired company is integrated into the new parent organization. Prior to this, Avella had a leadership team focused on national growth and operational excellence.
Discover the tools Avella Specialty Pharmacy uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition by Optum, Avella Specialty Pharmacy likely utilized standard corporate email address formats. Common patterns included combining the first initial and last name, or first name and last name separated by a dot, followed by the company domain.
[first_initial][last]@avella.com
Format
jdoe@avella.com
Example
75%
Success rate
Business Wire (Optum Press Release) • January 30, 2018
OptumRx, UnitedHealth Group's pharmacy care services business, announced it had completed its acquisition of Avella Specialty Pharmacy. The deal aimed to enhance patient access to specialized drugs and personalized clinical support for complex medical conditions....more
PR Newswire (RLH Equity Partners) • October 4, 2016
RLH Equity Partners announced its growth equity investment in Avella Specialty Pharmacy. This partnership was intended to support Avella's continued national expansion, enhancement of its patient-focused clinical services, and technological advancements....more
Avella Press Release / Inc. Magazine • August 17, 2016
Avella Specialty Pharmacy announced its tenth consecutive year on the Inc. 5000 list of fastest-growing private companies in America, a testament to its sustained growth and leadership in the specialty pharmacy sector....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Avella Specialty Pharmacy, are just a search away.